from the Finnish sample with the L326F variant and their carrier parents have been reported to suffer from mild to severe sleep disorders. However, no sleep impairments were observed in the Italian family with the L326F variant, and in individuals with the splice site and the stop mutation. The role of ASMT gene variants in sleep and neuropsychiatric disorders thus warrants further investigation.
The trace amine-associated receptor genes (TAARs) have been considered as important candidates for both schizophrenia (SZ) and bipolar disorder (BD) based on mapping, 1,2 expression 3 and association of TAAR6 (a.k.a. TRAR4) with BD and SZ. 4, 5 Clinical studies have demonstrated elevated urinary levels of one of the trace amines (b-phenylethylamine) in SZ and BD patients. 6, 7 To replicate the reported association and further explore roles of other trace amine receptors in BD susceptibility, we performed a family-based association analysis of all the known nine TAAR genes in 1310 samples, which consisted of 989 samples from the NIMH (National Institute of Mental Health) Genetics Initiative for Bipolar Disorder Waves 1-4 series (including waves 1-2: 23 trios and 83 quads; waves 3-4: 22 trios and 112 quads); 83 samples from the Clinical Neurogenetics (CNG) series (including 6 trios and 8 quads); and 238 samples from the ChicagoHopkins-Intramural Project (CHIP) series (including 14 trios and 49 quads). The NIMH wave 3 samples showed linkage with 6q23 in previous genome scan study. 8 All affected children met DSM-IV criteria for bipolar or schizoaffective bipolar type based on the Diagnostic Instrument for Genetic Studies, medical records and information from family informants. We used the affection status model that includes BPI, BPII and schizoaffective bipolar type in our association analyses. BPI only model was also tested. All samples were Caucasian except for nine families, which were identified as African or Asian by STRUCTURE 9 analysis using 254 unlinked SNPs (data not shown). These nine families (five in CNG and waves 1 and 2; four in waves 3 and 4 and CHIP) were excluded from analyses: 110 offspring in the families were females and 185 were males. The statistical power analysis performed using PBAT (http://www.biostat.harvard.edu/~clange/default.htm) (Supplementary Table S1) shows that this whole Caucasian sample (63 trios and 245 quads) has 80% power to detect association with odds ratios of 1.7 and 1.5 for allele frequency of 0.1 and 0.5, respectively.
Our strategy was to test a set of SNPs in a screening sample and to follow up SNPs that were nominally significant in our sample or in previous studies in a follow-up sample. Finally, SNPs were analyzed in the combined sample. Results in the follow-up sample were corrected for the number of tests performed for the markers genotyped in this sample. Results in the combined sample were corrected for the total number (30) of tests performed. Initially, we genotyped 30 SNPs in the CNG and NIMH wave 1-2 samples. The SNPs were selected from the HapMap Caucasian genotype data (release 16c.1) in the 127 kb region on 6q23, where all nine known trace amine receptor genes are located. We used Carlson's LD-Select algorithm 10 to select tag SNPs (tSNPs) with r 2 X0.85, minor allele frequency (MAF)X0.1, one tSNP from each linkage disequilibrium (LD) bin. SNPs with previously reported signals in SZ and BD, including rs4305745, rs6903874, rs6937506, rs8192624 and 4 rs8192625, rs4305745, rs6903874 and rs6937506 were nominally significant in an SZ study. 5 Detailed data including counts of transmitted and untransmitted alleles can be found in Supplementary Table S3 .
Letters to the Editor rs8192625 were also selected ( Table 1 ). The average genotyping success rates were 99.80 and 98.75% for pyrosequencing (two SNPs) and for TaqMan assays (28 SNPs), respectively. TDT tests using ASPEX 2.5/ sib_tdt (http://aspex.sourceforge.net/) detected four SNPs, including rs9389008, rs4628126, rs1569651 and rs9321360 nominally associated with BD (P < 0.05, Table 1 ). Haplotype blocks were identified by Haploview using the solid spine of LD (Supplementary Figure S1 ) and then analyzed for association by PDTPHASE. 11 One distal haplotype in the TAAR4 gene (named Hap1 here, which includes rs9389008, rs4628126, rs4320395 and rs12189813) showed nominal association with BD (P = 0.0063), with false discovery rate 12 q = 0.071. We then genotyped 12 SNPs in a second sample set including CHIP and NIMH wave 3-4 samples. SNP rs8192624 showed nominally significant association (P = 0.022) in the second set of samples (Table 1) , as well as in the combined samples (P = 0.0048). SNPs rs8192625 and rs4628126 showed P not greater than 0.05 only in combined data analysis ( Table 1 ). The haplotype Hap1 in this region showed similar results (P = 0.13 in the second set sample; P = 0.015 in combined data).
The major allele (G) of SNP rs8192624 and rs8192625 in TAAR6 gene was reported to be associated with BD or SZ. 4, 5 Here, we observed nominally significant association between minor allele (A) and BD. The reported allele frequency 4 is similar to that observed in this study. This alleviated our concern for allele call errors as a cause of the discrepant results.
TAAR6 is in a region where most markers are not in LD with each other. We resequenced a 1 kb exonic fragment and 1 kb of putative promoter of TAAR6 in 189 unrelated BD patients from NIMH BD Genetics Initiative and 188 age-and gender-matched mentally healthy unrelated controls from the NIMH Schizophrenia Genetics Initiative collection. Controls were defined as those who did not meet criteria for BD, schizoaffective disorder or SZ. In addition, our selected controls did not meet criteria for panic or recurrent depression that could be met by the diagnostic interview used for that collection.
Twenty-four variants, including eight common variants (MAF > 0.05), were identified from the resequencing. Fifteen of these variants were novel. Eleven variants were in a coding region with one synonymous and 10 nonsynonymous mutations (Supplementary  Table S2 ). We looked for a potential rare variant association, as implied in other studies. 13 One common synonymous variant (P26P) was detected in both cases and controls. Four missense mutations appeared uniquely in cases and one missense mutation appeared only in controls. However, no significant difference of distribution or amount of coding mutations was found between the BD and control samples. All singletons identified in patients were inherited from parents, as found by additional sequencing, and some from psychiatrically unaffected parents.
The resequencing data revealed very low LD among most variants in the TAAR6 gene region (data not shown). It is consistent with the rough map from the HapMap project. This also suggests that a true association, if any, in this region may only be detected by testing the causal variant directly.
In conclusion, the present study did not support strong association of either common or rare variants in the TAAR6 gene with BD susceptibility. SNPs rs8192624 and rs8192625 in TAAR6 and a haplotype in TAAR4 gene region remain interesting for possible minor contribution to disease susceptibility. Other candidate genes in this region should be further investigated.
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